metformin has been researched along with thromboxane b2 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernini, W; De Caterina, R; Giannarelli, R; Giannessi, D; Marchetti, P; Navalesi, R | 1 |
| Janka, HU | 1 |
| Colli, S; Ghiselli, G; Maderna, P; Sirtori, CR; Tremoli, E | 1 |
| Bosco, AA; Carvalho, Md; Duarte, RC; Dusse, LM; Fernandes, AP; Gomes, KB; Gonçalves, LH; Silva, MV | 1 |
1 trial(s) available for metformin and thromboxane b2
| Article | Year |
|---|---|
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels.
Topics: Aspirin; Biological Transport; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Hypoglycemic Agents; Insulin Resistance; Intestinal Absorption; Male; Metformin; Middle Aged; Oxidative Stress; Risk Factors; Thromboxane B2 | 2014 |
3 other study(ies) available for metformin and thromboxane b2
| Article | Year |
|---|---|
The direct effects of metformin on platelet function in vitro.
Topics: Adult; Blood Glucose; Blood Platelets; Humans; In Vitro Techniques; Metformin; Platelet Aggregation; Thromboxane B2 | 1989 |
Platelet and endothelial function tests during metformin treatment in diabetes mellitus (short communication).
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Antigens; beta-Thromboglobulin; Blood Platelets; Diabetes Mellitus, Type 2; Endothelium; Factor VIII; Female; Glyburide; Humans; Male; Metformin; Middle Aged; Platelet Aggregation; Thromboxane B2; von Willebrand Factor | 1985 |
Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits.
Topics: Animals; Blood Platelet Disorders; Blood Platelets; Cholesterol, Dietary; Collagen; Hypercholesterolemia; Hypersensitivity; Lipids; Male; Metformin; Plasma Exchange; Platelet Aggregation; Rabbits; Thromboxane B2 | 1982 |